Reins International Collaboration Members

Reins International Collaboration Members

<p>REiNS International Collaboration Members 2016</p><p>Shivani Ahlawat, MD (Johns Hopkins Medical Institute, Whole-Body MRI Working Group); Srivandana Akshintala, MBBS, MPH (National Institutes of Health, Functional Outcomes Working Group); Jeffrey Allen, MD (NYU Langone Medical Center, Member, Visual Outcomes Working Group); Simone Ardern-Holmes, MD (The Children’s Hospital at Westmead, Member, Tumor Measurement, Functional Outcomes, Visual Outcomes and Whole-Body MRI Working Groups); Robert Avery, DO (Children’s National Medical Center, Visual Outcomes Working Group); Amedeo Azizi, MD (Medical University of Vienna); Dusica Babovic-Vuksanovic, MD (Mayo Clinic, Member, Tumor Measurement and Functional Outcomes Working Groups); Annette Bakker, PhD (Children’s Tumor Foundation, President); Andrea Baldwin, CRNP (National Cancer Institute, Member, Patient-Reported Outcomes Working Group); Fred Barker, MD (Massachusetts General Hospital, Member, Tumor Measurement and Functional Outcomes Working Groups); Amanda Bergner, MS CGC (Johns Hopkins Comprehensive Neurofibromatosis Center, Member, Patient-Reported Outcomes Working Group); Chetan Bettegowda, MD, PhD (Johns Hopkins Medical Institute, Biomarkers Working Group); Sucharita Bhaumik, MD (Children’s National Medical Center); Larissa Bilaniuk, MD (The Children’s Hospital of Philadelphia, Member, Visual Outcomes Working Group); Kim Bischoff (Neurofibromatosis, Inc., Executive Director); Jaishri Blakely, MD (John Hopkins Medical Institute, Chair, Whole Body MRI Working Group; Member, Functional Outcomes and Biomarkers Working Groups); Diana Bradford (National Cancer Institute, Tumor Measurement Working Group); Miriam Bredella, MD (Massachusetts General Hospital, Member, Whole-Body MRI Working Group); Wenli Cai, PhD (Massachusetts General Hospital, Whole-Body MRI Working Group); John Carino, MD, MPH (Johns Hopkins Medical Institute, Member, Whole- Body MRI Working Group); Avneesh Chabra, MD (Johns Hopkins Medical Institute, Member, Whole-Body MRI Working Group); Patricia Ciavarelli (University of Buenos Aires); Wade Clapp, MD (Indiana University); Stephen Connor, MD (King’s College Hospital, Member, Tumor Measurement Working Group); Albert Cornelius, MD (Helen DeVos Children’s Hospital); Tambra Dahlheimer, MS, RN (Univeristy of Minnesota); Stephanie Davis, MD (Indiana University); Peter de Blank, MD (UH Rainbow Babies and Children's Hospital, Neurocognitive Working Group); Vidya Dhote (Children’s Tumor Foundation); Joni Doherty, PhD (House Research Institute, Functional Outcomes Working Group); Eva Dombi, MD (National Cancer Institute, Co-Chair, Tumor Measurement Working Group; Member, Whole-Body MRI Working Group); William Dudley, PhD (University of North Carolina Greensboro, Patient Reported Outcomes Working Group); Rachel Ershler, MD (National Institutes of Health; Tumor Measurement and Functional Outcomes Working Group); D. Gareth Evans, MD (St. Mary's Hospital, Member, Tumor Measurement, Whole-Body MRI and Functional Outcomes Working Groups); Laura Fayad, MD (Johns Hopkins Medical Institute, Member, Whole-Body MRI Working Group); Cristina Fernandez-Valle, PhD (University of Central Florida); Rosalie Ferner, MD (Guy's and St. Thomas Hospital, Member, Tumor Meaurement, Patient-Reported Outcomes, and Functional Outcomes Working Groups); Michael Fisher, MD (The Children’s Hospital of Philadelphia, Chair, Visual Outcomes Working Group; Member, Tumor Measurement Working Group); Barbara Franklin (Advocure NF2, Inc., Member, Patient-Reported Outcomes Working Group); Giulia Fulci, PhD (Massachusetts General Hospital); Tracy Galloway (Children’s Tumor Foundation); Kathy Gardner, MD (University of Pittsburgh, Member, Funtional Outcomes and Patient-Reported Outcomes Working Groups); Richard Gedrich (Kolltan Pharmaceuticals); Marco Giovannini, MD, PhD (University of CA Los Angeles) Amy Goldstein, MD (University of Pittsburgh); Anne Goodwin (National Cancer Institutes); Stephane Goutagny, MD, PhD (Hôpital Beaujon, Member, Tumor Measurement Working Group); David Gutmann, MD, PhD (Washington University School of Medicine, Member, Visual Outcomes Working Group); Theresa Hadlock, MD (Massachusetts Eye and Ear Infirmary Member, Functional Outcomes Working Group); Chris Halpin, PhD (Massachusetts Eye and Ear Infirmary, Member, Functional Outcomes Working Group); C. Oliver Hanemann, MD, PhD (Plymouth University Peninsula Schools of Medicine and Dentistry, Chair, Biomarkers Working Group); Kristina Hardy, PhD (Children’s National Medical Center, Member, Neurocognitive Outcomes Working Group); Gordon Harris, PhD (Massachusetts General Hospital, Member, Tumor Measurement and Whole-Body MRI Working Groups); Desiree Headley (Astra Zeneca); Gena Heidary, MD, PhD (Chidlren's Hospital Boston, Vision Outcomes Working Group); Jonathan Heller (Pfizer); Cynthia Hingtgen, MD, PhD (Michigan State University, Member, Patient-Reported Outcomes Working Group); Trent Hummel, MD (Cincinnati Children's Hospital, Functional Outcomes and Vision Outcomes Working Groups); Susan Huson, MD (Central Manchester University Hospitals NHS Trust, Member, Whole-Body MRI Working Group); Michael Jacobs, PhD (Johns Hopkins Medical Institute, Member, Whole-Body MRI Working Group); Jennifer Janusz, PsyD (University of Colorado School of Medicine, Neurocognitive Outcomes Working Group); Diego Jaramillo, MD (The Children’s Hospital of Philadelphia, Member, Tumor Measurement Working Group); Justin Jordan, MD (Massachusetts General Hospital); Allen Julian, MD (Children’s Hospital of Philadelphia, Functional Outcomes Working Group); Michel Kalamarides, MD (Hopital Beaujon, Tumor Measurement Working Group); Matthias Karajannis, MD (NYU Langone Medical Center, Member, Tumor Measurement and Biomarker Working Groups); Bonnie Klein-Tasman, PhD (University of Wisconsin-Milwaukee, Member, Neurocognitive Outcomes Working Group); Pamela Knight (Children’s Tumor Foundation); Bruce Korf, MD, PhD (University of Alabama at Birmingham, Member, Tumor Measurement Working Group); Shannon Langmead, NP (Johns Hopkins Medical Institute); Theresa LaVallee (Kolltan Pharmaceuticals); Fawn Leigh, MD (Massachusetts General Hospital); Donita Lightner, MD (University of Kentucky); Carol Lin, MD (Children's Hospital of Orange County); Robert Listernick, MD (Ann & Robert H. Lurie Children’s Hospital of Chicago, Member, Visual Outcomes Working Group); Grant Liu, MD (The Children’s Hospital of Philadelphia, Member, Visual Outcomes Working Group); Mevo Marco (Children's Tumor Foundation); Carole Marcus, MD (Children’s Hospital of Philadelphia); Gabriella Mariani (Astra Zeneca); Staci Martin, PhD (National Cancer Institute, Member, Patient-Reported Outcomes, Visual Outcomes and Neurocognitive Outcomes Working Groups); Victor Mautner, MD (University Medical Center Hamburg-Eppendorf, Member, Tumor Measurement and Whole-Body MRI Working Groups); Vanessa Merker, BS (Massachusetts General Hospital, Member, Patient-Reported Outcomes Working Group); Michael Ferguson, MD (Indiana University, Biomarkers Working Group); Chris Moertel, MD (University of Minnesota, Functional Outcomes Working Group); Jill Morris, PhD (National Institutes of Health); Katrina Morris, MD (Oxford University Hospitals); Kathryn North, MD (Royal Children’s Hospital, Member, Neurocognitive Outcomes Working Group); Fabio Nunes, MD (Eli Lilly and Company, Member, Biomarkers Working Group); Roger Packer, MD (Children's Medical Center); Laura Papi, MD, PhD (University of Florence); Allyson Parry, MD (Oxford University Hospitals); Neha Patel, MD (University of Wisconsin, Vision Outcomes Working Group); Jonathan Payne, PsyD (The Children’s Hospital at Westmead Member, Neurocognitive Outcomes Working Group); Karen Peluso (Neurofibromatosis, Inc.); Sebastian Perreault, MD (University of Montreal); Scott Plotkin, MD, PhD (Massachusetts General Hospital, Co-Chair, REiNS International Collaboratio; Chair, Functional Outcomes Working Group; Member, Tumor Measurement Working Group); Tina Poussaint, MD (Boston Children's Hospital, Member, Tumor Measurement Working Group); Nancy Ratner, PhD (Cincinnati Children's Hospital); Karlyne Reilly, PhD (National Institutes of Health); Vincent Riccardi, MD (NF Institute); Kent Robertson, MD, PhD (Riley Hospital for Children, Member, Functional Outcomes, Biomarkers and Tumor Measurement Working Groups); Claas Rohl (NF Kinder); Deborah Rukin Gold, MD (University Hospital of Cleveland); La Rosa Salvatore (Children’s Tumor Foundation); Laura Schaffner Gray, PhD (National Cancer Institute, Member, Neurocognitive Outcomes Working Group); Elizabeth Schorry, MD (Cincinnati Children's Hospital Medical Center, Functional Outcomes and Patient-Reported Outcomes Working Groups); Claire Semerjian, MA (Children’s National Medical Center, Neurocognitive Outcomes Working Group); Monica Sheridan, BA (Massachusetts General Hospital); Chie-Schin Shih, MD (Riley Hospital for Children, Member, Tumor Measurement Working Group); Carolyn Sidor (Kolltan Pharmaceuticals); William Slattery III, MD (House Clinic, Member, Functional Outcomes Working Group); Miriam Smith, PhD (St. Mary’s Hospital); Kathy Sommer, RN (University of Minnesota, Neurocognitive Outcomes Working Group); Marigo Stathis (Johns Hopkins Medical Institute); Matt Steensma, MD (Van Andel Institute); Anat Stemmer-Rachamimov, MD (Massachusetts General Hospital, Member, Biomarkers Working Group); David Stevenson, MD (University of Utah); Kari Struemph, PhD (National Institutes of Health); Lara Sullivan (Pfizer); Mary Anne Tamula, MA (NIH Clinical Monitoring Research Program, Member, Neurocognitive Outcomes Workin Group); Mary Thomas (Guy's Hospital); Heather Thompson, PhD, CCC-SLP (California State University, Patient Reported Outcomes Working Group); James Tonsgard, MD (University of Chicago, Member, Functional Outcomes and Patient-Reported Outcomes Working Groups); Nicole Ullrich, MD, PhD (Boston Children’s Hospital, Member, Visual Outcomes and Neurocognitive Working Groups); Sharad Verma, PhD (Johns Hopkins University); David Viskochil, MD, PhD (University of Utah, Functional Outcomes Working Group); Ana-Maria Vranceanu, PhD (Massachusetts General Hospital, Patient Reported Outcomes Working Group); Ute Wahllander (LMU Munich, Functional Outcomes Working Group); Karin Walsh, PsyD (Children’s National Medical Center, Chair, Neurocognitive Outcomes Working Group); Bradley Welling, MD PhD (Ohio State University, Member, Functional Outcomes Working Group); Ralph Wenzel, MD (University Medical Center Hamburg- Eppendorf, Member, Whole-Body MRI Working Group); Trish Whitcomb, RN (National Institutes of Health); Brigitte Widemann, MD (National Cancer Institute, Co-Chair, REiNS Internation Collaboration; Co-chair, Tumor Measurement Working Group; Member, Whole-Body MRI Working Group); Victoria Williams, MD (Guy's Hospital); David Wolf, MD, PhD (Emory University, Functional Outcomes Working Group); Pamela Wolters, PhD (National Cancer Institute, Chair, Patient-Reported Outcomes Working Group; Member, Neurocognitive Outcomes Working Group); Kaleb Yohay, MD (NYU Langone Medical Center, Biomarkers Working Group).</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    4 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us